Metraipolis › archive › dc_be66371895ea

Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations — Europe PMC PMID:42180537

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42180537
DOI
10.1016/j.apsb.2026.03.031
License (as archived)
solo-consultazione
Archived
2026-11-04T03:55:35.496Z
SHA-256 of the archived text
6fc5e1f0514bb06101e42bae108dd19e37fd379691c13b9343540be6f87b7385
Stable URL of this page
https://metraipolis.com/documento/dc_be66371895ea

How to cite

Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations — Europe PMC PMID:42180537 — Europe PMC (en), https://europepmc.org/article/MED/42180537 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be66371895ea (Metraipolis archive dc_be66371895ea, sha256 6fc5e1f0514bb06101e42bae108dd19e37fd379691c13b9343540be6f87b7385)
BibTeX
@misc{dcbe66371895ea,
  title = {Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations — Europe PMC PMID:42180537},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42180537},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be66371895ea; sha256 6fc5e1f0514bb06101e42bae108dd19e37fd379691c13b9343540be6f87b7385},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42180537. Agents can read the archived copy with the MCP tool read_document.